Cart
sales@molnova.com
Diosbulbin B
CAS No. 20086-06-0
Diosbulbin B( —— )
Catalog No. M18200 CAS No. 20086-06-0
Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 33 | In Stock |
|
| 25MG | 69 | In Stock |
|
| 50MG | 99 | In Stock |
|
| 100MG | 145 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiosbulbin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.
-
DescriptionDiosbulbin B exhibits potential hepatotoxicity. Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGlucokinase
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number20086-06-0
-
Formula Weight344.36
-
Molecular FormulaC19H20O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16 mg/mL (46.46 mM)
-
SMILESCC12CC(OC13CC(C4C2CC5CC4C(=O)O5)OC3=O)C6=COC=C6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Acarbose
Acarbose is an inhibitor of intestinal alpha-glucosidase, used to treat type 2 diabetes mellitus.
-
ARRY-403
ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
-
Manghaslin
Manghaslin has considerable α-glucosidase inhibitory activity, illustrating the anti-diabetic potential of phenolic-rich litchi pulp extracts. Manghaslin also shows inhibitory activity against AChE
